Rational Design of a Glycoconjugate Vaccine against Group A Streptococcus

No commercial vaccine is yet available against Group A Streptococcus (GAS), major cause of pharyngitis and impetigo, with a high frequency of serious sequelae in low- and middle-income countries. Group A Carbohydrate (GAC), conjugated to an appropriate carrier protein, has been proposed as an attrac...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Benedetto, Roberta, Mancini, Francesca, Carducci, Martina, Gasperini, Gianmarco, Moriel, Danilo Gomes, Saul, Allan, Necchi, Francesca, Rappuoli, Rino, Micoli, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696035/
https://www.ncbi.nlm.nih.gov/pubmed/33202815
http://dx.doi.org/10.3390/ijms21228558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696035/
https://www.ncbi.nlm.nih.gov/pubmed/33202815
http://dx.doi.org/10.3390/ijms21228558

Ejemplares similares